BIOMAT Database Logo BIOMAT Database Logo

Guidelines for radioiodine therapy of differentiated thyroid cancer. 2008

M Luster, and S E Clarke, and M Dietlein, and M Lassmann, and P Lind, and W J G Oyen, and J Tennvall, and E Bombardieri, and
Department of Nuclear Medicine, University of Würzburg, Josef-Schneider-Strasse 2, 97080 Würzburg, Germany. luster@nuklearmedizin.uni-wuerzburg.de

BACKGROUND The purpose of the present guidelines on the radioiodine therapy (RAIT) of differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear Medicine (EANM) Therapy Committee is to provide advice to nuclear medicine clinicians and other members of the DTC-treating community on how to ablate thyroid remnant or treat inoperable advanced DTC or both employing large 131-iodine ((131)I) activities. CONCLUSIONS For this purpose, recommendations have been formulated based on recent literature and expert opinion regarding the rationale, indications and contraindications for these procedures, as well as the radioiodine activities and the administration and patient preparation techniques to be used. Recommendations also are provided on pre-RAIT history and examinations, patient counselling and precautions that should be associated with (131)I iodine ablation and treatment. Furthermore, potential side effects of radioiodine therapy and alternate or additional treatments to this modality are reviewed. Appendices furnish information on dosimetry and post-therapy scintigraphy.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D009683 Nuclear Medicine A specialty field of radiology concerned with diagnostic, therapeutic, and investigative use of radioactive compounds. Atomic Medicine,Nuclear Radiology,Medicine, Atomic,Medicine, Nuclear,Radiology, Nuclear
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013964 Thyroid Neoplasms Tumors or cancer of the THYROID GLAND. Cancer of Thyroid,Thyroid Cancer,Cancer of the Thyroid,Neoplasms, Thyroid,Thyroid Adenoma,Thyroid Carcinoma,Adenoma, Thyroid,Adenomas, Thyroid,Cancer, Thyroid,Cancers, Thyroid,Carcinoma, Thyroid,Carcinomas, Thyroid,Neoplasm, Thyroid,Thyroid Adenomas,Thyroid Cancers,Thyroid Carcinomas,Thyroid Neoplasm
D017410 Practice Guidelines as Topic Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery. Clinical Guidelines as Topic,Best Practices,Best Practice
D018787 Radiation Oncology A subspecialty of medical oncology and radiology concerned with the radiotherapy of cancer. Oncology, Radiation,Radiology, Therapeutic,Therapeutic Radiology
D019275 Radiopharmaceuticals Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) Radiopharmaceutical

Related Publications

M Luster, and S E Clarke, and M Dietlein, and M Lassmann, and P Lind, and W J G Oyen, and J Tennvall, and E Bombardieri, and
[Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer].
January 1999, Nuklearmedizin. Nuclear medicine,
M Luster, and S E Clarke, and M Dietlein, and M Lassmann, and P Lind, and W J G Oyen, and J Tennvall, and E Bombardieri, and
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)].
January 2007, Nuklearmedizin. Nuclear medicine,
M Luster, and S E Clarke, and M Dietlein, and M Lassmann, and P Lind, and W J G Oyen, and J Tennvall, and E Bombardieri, and
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 2)].
August 2004, Nuklearmedizin. Nuclear medicine,
M Luster, and S E Clarke, and M Dietlein, and M Lassmann, and P Lind, and W J G Oyen, and J Tennvall, and E Bombardieri, and
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4].
June 2016, Nuklearmedizin. Nuclear medicine,
M Luster, and S E Clarke, and M Dietlein, and M Lassmann, and P Lind, and W J G Oyen, and J Tennvall, and E Bombardieri, and
Conventional Radioiodine Therapy for Differentiated Thyroid Cancer.
March 2019, Endocrinology and metabolism clinics of North America,
M Luster, and S E Clarke, and M Dietlein, and M Lassmann, and P Lind, and W J G Oyen, and J Tennvall, and E Bombardieri, and
Radioiodine therapy for differentiated thyroid carcinoma.
December 1988, American journal of surgery,
M Luster, and S E Clarke, and M Dietlein, and M Lassmann, and P Lind, and W J G Oyen, and J Tennvall, and E Bombardieri, and
[The basis for radioiodine therapy in differentiated thyroid cancer].
July 1999, Therapeutische Umschau. Revue therapeutique,
M Luster, and S E Clarke, and M Dietlein, and M Lassmann, and P Lind, and W J G Oyen, and J Tennvall, and E Bombardieri, and
Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice.
January 2005, Nuklearmedizin. Nuclear medicine,
M Luster, and S E Clarke, and M Dietlein, and M Lassmann, and P Lind, and W J G Oyen, and J Tennvall, and E Bombardieri, and
Radioiodine treatment for differentiated thyroid cancer.
January 2000, Clinical oncology (Royal College of Radiologists (Great Britain)),
M Luster, and S E Clarke, and M Dietlein, and M Lassmann, and P Lind, and W J G Oyen, and J Tennvall, and E Bombardieri, and
Differentiated thyroid carcinoma referred for radioiodine therapy.
June 2001, Saudi medical journal,
Copied contents to your clipboard!